首页
个人中心
委托采购
采购清单

网站主页 LEU-VAL-PHE-PHE-ALA-GLU-ASP-VAL-GLY-SER-ASN-LYS-GLY-ALA-ILE-ILE-GLY-LEU-MET-VAL-GLY-GLY-VAL-VAL-ILE-ALA: LVFFAEDVGSNKGAIIGLMVGGVVIA Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala

Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala

Amyloid 17-42

浙江更新日期：2024-02-19

浙江湃肽生物股份有限公司

VIP12年

科技型中小企业

高新技术企业

联系人：孟经理

电话：0571-89197072;拨打

手机：18668118770 拨打

邮箱：linda@peptide-china.com

产品详情:

中文名称：: Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala

英文名称：: Amyloid 17-42

品牌：: ZPC-杭州湃肽生化

产地：: 杭州

保存条件：: 短期2°-8°，长期-20°

纯度规格：: 95%，98%，根据客户要求定制纯度

▼

▲

Amylins

Amylin (1-13), human

Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala

Amylin (8-37), human

Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr

Amylin (8-37), Human (Free Acid)

Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr

Amylin (8-37), rat

Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2

Adipokinetic Hormones

Adipokinetic Hormone

Glp-Leu-Thr-Phe-Thr-Ser-Trp-Gly-NH2

Adipokinetic Hormone (Apis mellifera ligustica, Bombyxmori, Heliothis zea, Manduca sexta)

Glp-Leu-Thr-Phe-Thr-Ser-Ser-Trp-Gly-NH2

Adipokinetic Hormone (Taa-AKH)(Tabanus atratus)

Glp-Leu-Thr-Phe-Thr-Pro-Gly-Trp-NH2

Adipokinetic Hormone G (AKH-G)(Gryllus bimaculatus)

Glp-Val-Asn-Phe-Ser-Thr-Gly-Trp-NH2

Adipokinetic Hormone II

Glp-Leu-Asn-Phe-Ser-Thr-Gly-Trp-NH2

Adipokinetic Hormone II

Glp-Leu-Asn-Phe-Ser-Ala-Gly-Trp-NH2

Adipokinetic Hormone, AKH, locust

Glp-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-Thr-NH2

[Tyr1] Adipokinetic Hormone, locust

Tyr-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-Thr-NH2

Amyloids & Related Peptides

Amyloid 17-42

Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala

Adrenocorticotropic Hormones (ACTH)

(D-Lys16)-ACTH (1-24) human, bovine, mouse, ovine, porcine, rabbit, rat

Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-DLys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro

(DSer1)-ACTH (1-24) (human, bovine, mouse, ovine, porcine, rabbit, rat)

DSer-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro

(p-Iodo-Phe7)-ACTH (4-10)

Met-Glu-His-p-iodo-Phe-Arg-Trp-Gly

(Tyr15)-ACTH (7-15)

Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Tyr

Acetyl-ACTH (1-14)

Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly

ACTH (1-10), human

Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly

ACTH (1-13), human

Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val

ACTH (1-14)

Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly

ACTH (1-16), human

Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys

ACTH (1-17), human

Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg

ACTH (1-24), human

Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro

ACTH (1-39), guinea pig

Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Ala-Asn-Gly-Ala-Glu-Glu-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe

ACTH (1-39), human

Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe

ACTH (1-39), rat

Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe

ACTH (1-4)

Ser-Tyr-Ser-Met

ACTH (11-24)

Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro

ACTH (12-39), rat

Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe

ACTH (18-39), human

Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe

ACTH (22-39)

Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe

ACTH (3-24) (human, bovine, mouse, ovine, porcine, rabbit, rat)

Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro

ACTH (34-39)

Ala-Phe-Pro-Leu-Glu-Phe

ACTH (4-10), human

Met-Glu-His-Phe-Arg-Trp-Gly

ACTH (4-11), human

Met-Glu-His-Phe-Arg-Trp-Gly-Lys

ACTH (4-9)

Met-Glu-His-Phe-Arg-Trp

ACTH (5-10)

Glu-His-Phe-Arg-Trp-Gly

ACTH (6-24), human

His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro

ACTH (7-38), human

Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu

Biotin-ACTH (1-39), Human

Biotin-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe

Corticostatin, human

Val-Cys-Ser-Cys-Arg-Leu-Val-Phe-Cys-Arg-Arg-Thr-Glu-Leu-Arg-Val-Gly-Asn-Cys-Leu-Ile-Gly-Gly-Val-Ser-Phe-Thr-Tyr-Cys-Cys-Thr-Arg-Val

Corticostatin, rabbit

Gly-Ile-Cys-Ala-Cys-Arg-Arg-Arg-Phe-Cys-Pro-Asn-Ser-Glu-Arg-Phe-Ser-Gly-Tyr-Cys-Arg-Val-Asn-Gly-Ala-Arg-Tyr-Val-Arg-Cys-Cys-Ser-Arg-Arg

N-Acetyl, ACTH (1-17), human

Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg

Tyr-ACTH (4-10)

Tyr-Met-Glu-His-Phe-Arg-Trp-Gly

Tyr-ACTH (4-9)

Tyr-Met-Glu-His-Phe-Arg-Trp

[Phe2,Nle4] ACTH (1-24), human

Ser-Phe-Ser-Nle-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro

淀粉肽I;Amyloid 17-42;多肽合成；peptide；Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala

浙江湃肽生物有限公司（简称：ZPC)成立于2015年7月，目前已经取得"药品生产许可证"，是一家专注于多肽产业化的cGMP工厂。2018年，公司获得“国家高新技术企业”称号。 ZPC位于绍兴市高新技术产业园，注册资本2000万元，公司一期占地面积为13亩，建有1万余平方米面积的符合cGMP/FDA标准的厂房，具有年产多肽原料药200KG的生产能力，可满足规模化药用多肽生产，根据生产需求，可扩展二期厂房近80亩。公司现有员工200多人，其中研发人员有60余人，目前已经取得多项发明专利，产品远销海内外，同全球很多制药企业建立了长期战略合作关系。浙江湃肽生物可以提供的产品有：GMP级别多肽（药物肽），非GMP级别多肽（药物肽杂质及中间体、多肽定制合成和修饰、化妆品用美容肽）。可以提供的服务有：多肽CRO委托研发，包括多肽关联申报、上市许可持有人(MAH）、多肽制剂一致性评价、多肽项目转让、多肽工艺优化及多肽新药的药学质量研究(CMC）等；多肽CMO委托生产及多肽CDMO，包括新药的临床前、临床1期、2期和3期的样品，及中试阶段的验证批产品等。

成立日期	(12年)
注册资本	4170.9196万人民币
员工人数	50-100人
年营业额	￥ 5000万-1亿
经营模式	工厂,试剂,定制,服务
主营行业	合成材料中间体,生物活性小分子,原料药,氨基酸及其衍生物